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Mannose  binding  lectin  (MBL)  is a serum  collagenous  C-type  lectin  that  plays  an  important  role in the
innate  immune  protection  against  pathogens.  Previously,  human  and mouse  studies  have  demonstrated
that  MBL  binds  a broad  range  of pathogens  that  results  in  their  neutralization  through  agglutination,
enhanced  phagocytosis,  and/or  complement  activation  via  the  lectin  pathway.  The  role  of  MBL  in chicken
is  not  well  understood  although  the  MBL  concentration  in  serum  seems  to  correlate  with  protection
against  infections.  To investigate  the  role of  MBL  in  chicken  further,  recombinant  chicken  MBL  (RcMBL)
was  produced  in HeLa  R19  cells  and  puriﬁed  using  mannan  afﬁnity  chromatography  followed  by  gel ﬁltra-
tion.  RcMBL  was  shown  to be  structurally  and  functionally  similar  to  native  chicken  MBL  (NcMBL)  isolated
from  serum.  RcMBL  is expressed  as  an  oligomeric  protein  (mixture  of  trimers  and  oligomerized  trimers)
with  a  monomeric  mass  of  26  kDa  as determined  by mass  spectrometry,  corresponding  to  the predicted
mass.  Glycan  array analysis  indicated  that  RcMBL  bound  most  strongly  to  high-mannose  glycans  but  also
glycans  with  terminal  fucose  and  GlcNac  residues.  The  biological  activity  of  RcMBL  was  demonstrated
via  its capacity  to agglutinate  Salmonella  Typhimurium  and  to inhibit  the  hemagglutination  activity  of
inﬂuenza  A  virus.  The  production  of  a structurally  well-characterized  and  functionally  active  RcMBL  will
facilitate  detailed  studies  into  the  protective  role  of  MBL  in  innate  defense  against  pathogens  in  chicken
and  other  avian  species.
©  2016  The  Author(s).  Published  by  Elsevier  GmbH.  This  is  an open  access  article  under  the  CC  BY. Introduction
Mannose binding lectin (MBL) is a serum collectin (collagenous
-type lectin), which plays an important role in the innate immune
esponse. Like all members of the collectin family, MBL  binds andPlease cite this article in press as: Zhang, W.,  et al., Expression and c
Immunobiology (2016), http://dx.doi.org/10.1016/j.imbio.2016.10.019
ecognizes a wide range of pathogens, including fungi, bacteria,
iruses and parasites, leading to agglutination and neutralization
f these microorganisms. In addition, the attachment of MBL  to
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the microbial surface induces the innate immune responses, such
as enhanced phagocytosis by macrophages. A third, probably best
known function of MBL  is that it can activate the complement sys-
tem via the lectin pathway. MBL  binding to pathogens activates
MBL-associated serine protease (MASP)-1 and MASP-2, of which
the latter cleaves complement factors C4 and C2 to generate a
C3 convertase, C4bC2a, aiding in clearance of infection (Dommett
et al., 2006; Ikeda et al., 1987; Ip et al., 2009; Thiel et al., 1997).
Many studies have underlined the importance of MBL  in human
and other mammalian species, often showing correlation between
low levels of serum hMBL (or hMBL-deﬁciency) are with suscepti-
bility to bacterial and viral infections (Davies et al., 2004; Hibberdharacterization of recombinant chicken mannose binding lectin.
et al., 1999; Ling et al., 2012; Shi et al., 2004). However, there are
some conﬂicting reports as well describing detrimental effects of
(higher levels of) MBL, indicating that MBL  function in vivo is very
complex, as summarized nicely in a recent meta-analysis on cor-
icle under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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elation between MBL  levels and disease susceptibility in human
Heitzeneder et al., 2012).
MBL  is synthesized in the liver and is predominantly present in
lood serum as multimeric proteins (Sheriff et al., 1994; Turner,
996). The polypeptide domain organization of MBL  is shared
y all members of the collectin family and is characterized by a
hort N-terminal cysteine-rich region, a collagen-like region con-
aining Gly-Xaa-Yaa repeats, and an -helical coiled-coil neck
egion followed by a carbohydrate recognition domain (CRD, or
ectin domain). The neck region initiates trimerization of three
olypeptides to form the functional subunit of MBL  which is sta-
ilized by the formation of the collagen triple helix and a disulﬁde
ond between cysteine residues at the N-terminal domain of MBL
reviewed by (Petersen et al., 2001)). Trimerization of MBL  not
nly facilitates the formation of the collagen triple helix but also
enerates a cluster of three adjacent CRDs that makes MBL, like
ll collectins, a “pattern recognition molecule”, having the ability
o interact with speciﬁc pathogen-associated molecular patterns
PAMPs). Further oligomerization of trimers is established through
-terminal linkage of MBL  trimers. Human MBL  is assembled into
arious degrees of multimerization, ranging from dimers to hex-
mers of trimeric subunits that resemble a “bouquet of tulips”, as
isualized by electron microscopy (Jensenius et al., 2009; Lu et al.,
990).
Previously, MBL  has been isolated from chicken serum and was
haracterized as a complex of oligomers consisting of 3–6 trimeric
ubunits (Laursen et al., 1995). The average chicken MBL  (cMBL)
oncentration in serum is approximately 6 g/ml but there is a high
oncentration range among chicken (between 0.4–37.8 g/ml),
ossibly caused by polymorphisms in the promotor region of cMBL
Kjaerup et al., 2013). However, based on studies with 308 chick-
ns, representing 14 different chicken lines, no cMBL-deﬁciency
as been found in any of these different breeds (Laursen et al.,
998b). The deduced amino acid sequence of cMBL shares approx-
mately 40% similarity with mammalian MBLs, in which especially
he collagen-like domain and the neck region are highly conserved
Laursen et al., 1998a). Like for all MBLs, serum derived cMBL binds
arbohydrates via its CRD in a Ca2+-dependent manner and the
ugar binding selectivity of cMBL is similar to that of hMBL (Laursen
t al., 1995).
Only a few studies have shed light on the functional importance
f MBL  in chicken. Most in vivo studies have been performed with
wo chicken inbred lines with relatively high (L10H) or low (L10L)
erum concentrations of cMBL as compared to outbred lines (Juul-
adsen et al., 2007). The concentration of cMBL seems to correlate
nversely with bacterial and viral infections in these two inbred
ines. In an E. coli challenge experiment, L10L chicken showed sig-
iﬁcantly reduced gain in body weight upon infection than L10H
hicken (Norup et al., 2009). Furthermore it was shown that upon
nfectious bronchitis virus infection, cMBL acted as an acute phase
rotein, inhibited viral propagation in the trachea, possibly by acti-
ating the complement system, as cMBL was shown to be able to
eposit human C4b on the cMBL/MASP complex (Juul-Madsen et al.,
007).
Detailed studies, aimed to investigate the structure and func-
ion of native cMBL (NcMBL) in vitro, have been complicated by
ifﬁculties in obtaining high yields and consistent batches of puri-
ed NcMBL. For human studies, a recombinant version of hMBL
as successfully produced using mammalian cells, such as Chi-
ese Hamster Ovary (CHO) cells and Human Embryonic Kidney
HEK) 293 cells, resulting in high yields of recombinant human
BL  (RhMBL) with structural and functional properties similar toPlease cite this article in press as: Zhang, W.,  et al., Expression and c
Immunobiology (2016), http://dx.doi.org/10.1016/j.imbio.2016.10.01
lasma derived hMBL (Ahn et al., 2013; Ohtani et al., 1999; Vorup-
ensen et al., 2001). In our study, this approach was adapted and
urther modiﬁed to produce recombinant chicken MBL  (RcMBL)
sing Human Cervical adenocarcinoma (HeLa) R19 cells. In this PRESS
gy xxx (2016) xxx–xxx
paper we describe the production and characterization of RcMBL
that exhibits structural and functional characteristics similar to that
of NcMBL. The availability of well-characterized and fully functional
RcMBL will be an important tool to enable further studies into espe-
cially molecular MBL-pathogen interactions in aid to identify MBLs
role in infections in chicken and other avian species.
2. Materials and methods
2.1. RNA isolation and cloning of MBL cDNA
Total RNA was obtained from chicken liver tissue (Ross 308)
using the High Pure RNA Tissue Kit (Roche, Germany) and digested
with DNase I (Roche) to eliminate genomic contamination. The
ﬁrst − strand cDNA was synthesized using the iScript cDNA syn-
thesis kit (BIO − RAD, USA). The coding sequence (CDS) of cMBL,
without the signal peptide’s sequence (GenBank Accession No.
AF231714) was  obtained by polymerase chain reaction (PCR) using
gene speciﬁc primers. Forward primer: 5′− GAG CTA GCG TTA CTT
ACC ACA GAT AAA CCT G −3′, and reverse primer: 5′− GAT TAA
TTA ATC ACA ATT CAC AAA TAA TGA AG −3′. PCR ampliﬁcation was
performed at 95 ◦C for 5 min, followed by 40 cycles at 95 ◦C for 30 s,
53 ◦C for 30 s, 72 ◦C for 150s, and a ﬁnal extension at 72 ◦C for 7 min.
The PCR product was puriﬁed using the QIAEX II Gel Extraction Kit
(Qiagen, Germany) and ligated into the pJET cloning vector (Thermo
Scientiﬁc, USA), afterwards transformed into DH5 competent cells
(Invitrogen, USA). The positive clones were selected and sequenced.
The ampliﬁed DNA fragment was digested with NheI and PacI and
sub-cloned into the expression vector pFRT (Thermo Scientiﬁc)
which was  previously cut with the same restriction enzymes. The
resulting construct, pFRT − cMBL was  veriﬁed by sequencing anal-
ysis.
2.2. Recombinant expression of cMBL using Hela cells
HeLa R19 cells, a gift from Dr. Wentao Li (Utrecht Univer-
sity, The Netherlands), were used to produce RcMBL. The cells
were maintained in a humidiﬁed 37 ◦C incubator with 5% CO2,
and cultured in Dulbecco’s Modiﬁed Eagle Medium (DMEM, Gibco,
United Kingdom) supplemented with 10% Fetal Bovine Serum
(FBS) (Bodinco BV, The Netherlands), penicillin (100 units/ml) and
streptomycin (100 g/ml). The pFRT expression vector containing
the cMBL encoding sequence was  transfected into 80% conﬂu-
ent Hela R19 cells using polyethyleneimine (PEI) (Polysciences,
USA) in a 1:5 ratio (g DNA: g PEI). At 12 h post transfection,
the transfection mixture was replaced by 293 SFM II expres-
sion medium (Gibco), supplemented with GlutaMax (10 ml/liter,
Gibco), primatone (3 g/l, Sigma − Aldrich, USA), d-glucose (2 g/l,
Sigma − Aldrich), sodium bicarbonate (3.7 g/l, Merck, Germany),
DMSO (15 ml/l, Sigma − Aldrich), penicillin (100 units/ml) and
streptomycin (100 g/ml). The expression medium was harvested
at 5 days post transfection (de Vries et al., 2010; Longo et al., 2013).
2.3. Puriﬁcation of RcMBL
RcMBL was puriﬁed from the HeLa R19 expression medium
using mannan afﬁnity chromatography. The medium was  calci-
ﬁed to a ﬁnal concentration of 5 mM CaCl2 followed by addition
of mannan agarose beads (4 ml  bed volume of beads/l of medium,
Sigma − Aldrich) and incubated while shaking overnight at 4 ◦C. The
beads were collected and washed extensively with TBS/Ca2+ buffer
(10 mM Tris − HCl pH = 7.4, 150 mM NaCl, 5 mM CaCl2) to removeharacterization of recombinant chicken mannose binding lectin.
9
all unspeciﬁc bound proteins.
Mannan bound RcMBL was  eluted with TBS/EDTA buffer (10 mM
Tris − HCl pH = 7.4, 150 mM NaCl, 5 mM EDTA), passed through
a 0.22 m ﬁlter and concentrated to approximately 1.5 ml  using
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micon Ultra − 15 centrifugal ﬁlters (Merck Millipore, Germany)
ith a cut-off of 10 kDa. Next, the concentrated RcMBL was sub-
ected to gel ﬁltration chromatography to separate the various
ligomeric forms of RcMBL using an ÄKTA puriﬁer10 system (GE
ealthcare Bio Sciences, Sweden), that was equipped with a Hiload
6/60 Superdex 200 PREP GRADE column and equilibrated in
BS buffer (10 mM Tris − HCl pH = 7.4, 150 mM NaCl). Fractions
rom each eluted peak were analyzed by non-reducing or reduc-
ng SDS − PAGE. Pooled fractions were concentrated by Amicon
ltra − 15 centrifugation and stored in aliquots at −20 ◦C.
.4. SDS-PAGE and western blotting of RcMBL
The concentration of puriﬁed RcMBL was determined using a
CA Protein Assay Kit (Thermo Scientiﬁc). Protein samples were
eparated on Mini-Protean TGX 4–15% precast gels (Bio-Rad, USA)
nder reducing or non-reducing conditions, and subsequently
isualized by EZBlue gel staining reagent (Sigma − Aldrich) or
ransferred onto 0.2 m Nitrocellulose membranes (Bio − Rad) for
estern blotting analysis. Immunodetection of RcMBL was  per-
ormed using a mouse monoclonal antibody against cMBL (6B11,
YB 182 − 01 − 02, Thermo Scientiﬁc) according to the manu-
acturer’s instructions. The secondary antibody used was a goat
nti − mouse IgG − Peroxidase (Sigma − Aldrich).
.5. Sequence alignment of the CRD of cMBL with mammalian
BLs and structural modelling of cMBL
Chicken and mammalian MBLs and human SP-D (hSP-
) sequences were obtained from the National Center for
iotechnology Information with the following Genbank acces-
ion codes: human SP-D (hSP-D; L05483.1), chicken MBL
cMBL; AF231714.1), human MBL  (hMBL; CAB56124.1), canine
BL-C (caMBLC; XP 536402.2), monkey MBL-A and −C (moMBL-
; XP 001096399 and moMBL-C; NP 001099005.1), rat MBL
rMBL; NM 012599.2), mouse MBL  (mMBL; NM 010775.2), bovine
BL  (bMBL; AAI09675.1), porcine MBL-A and −C (pMBLA;
P 001007195.1 and pMBLC; NP 999290.1). The structural mod-
lling of the neck region and the CRD of cMBL was  predicted using
TASSER software as described previously (Yang et al., 2015).
.6. Liquid chromatography-tandem mass spectrometry
LC–MS/MS) of RcMBL
RcMBL (200 g/ml, stored in TBS buffer) was diluted with XT
ample buffer (Bio-Rad) and proteins were subsequently separated
n a precast 12% Bis-Tris gel (Bio-Rad) under reducing condi-
ions. After staining of the SDS-PAGE gel with GelCode Blue stain
Pierce, USA), the RcMBL protein band was excised, proteins in
he gel plug were reduced with DTT (1 h at 60◦ C) and subse-
uently alkylated using chloroacetamide (30 min at RT in the dark).
n-gel digestion with 3 ng/l trypsin (Gold, Mass Spectrometry
rade, Promega) in 50 mM ammonium bicarbonate (pH = 8.5) was
erformed overnight at 37 ◦C. After digestion, the RcMBL-derived
eptides were extracted with acetonitrile and dried in a speed vac-
um centrifuge. Prior to mass spectrometry analysis, the peptides
ere reconstituted in 10% formic acid.
Peptides were separated using the Proxeon nLC 1000 sys-
em (Thermo Scientiﬁc, Bremen) ﬁtted with a trapping column
ReproSil-Pur 120 C18-AQ 3 m (Dr. Maisch GmbH, Ammerbuch,
ermany); 100 m x 30 mm)  and an analytical column (ReproSil-
ur 120 C18-AQ 2.4 m (Dr. Maisch GmbH); 75 m x 500 mm),  bothPlease cite this article in press as: Zhang, W.,  et al., Expression and c
Immunobiology (2016), http://dx.doi.org/10.1016/j.imbio.2016.10.019
acked in-house. The outlet of the analytical column was  coupled
irectly to a Thermo Orbitrap Fusion hybrid mass spectrometer
Q-OT-qIT, Thermo Scientiﬁc) using the Proxeon nanoﬂex source.
anospray was achieved using a distally coated fused silica tip PRESS
gy xxx (2016) xxx–xxx 3
emitter (generated in-house, o.d. 375 m,  i.d. 20 m) operated at
2.1 kV. Solvent A was  0.1% formic acid/water and solvent B was 0.1%
formic acid/ACN. An aliquot (25%) of the in-gel digest was  eluted
from the analytical column at a constant ﬂow rate of 250 l/min in
a 35-min gradient, containing a linear increase from 7% to 25% sol-
vent B, followed by wash at 80% solvent B. Survey scans of peptide
precursors from m/z 375–1500 were performed at 120 K resolu-
tion with a 4 × 105 ion count target. Tandem MS  was performed
by quadrupole isolation at 1.6 Th, followed by HCD fragmentation
with normalized collision energy of 33 and ion trap MS2  fragment
detection. The MS2  ion count target was  set to 104 and the max
injection time was set to 50 ms.  Only precursors with charge state
2–6 were sampled for MS2. Monoisotopic precursor selection was
turned on; the dynamic exclusion duration was set to 30 s with a
10 ppm tolerance around the selected precursor and its isotopes.
The instrument was run in top speed mode with 3 s cycles.
Raw data ﬁles were processed using Proteome Discoverer (ver-
sion 1.4.1.14, Thermo Fisher Scientiﬁc). MS2 spectra were searched
against the Uniprot chicken database (Uniprot Gallus Gallus, release
20110418, 15344 sequences) using Mascot (version 2.4.1, Matrix
Science, UK). Carbamidomethylation of cysteines was  set as ﬁxed
modiﬁcation and oxidation of methionine was set as a variable
modiﬁcation. Trypsin was  speciﬁed as protease and up to two
miscleavages were allowed. Data ﬁltering was  performed using
percolator, resulting in 1% false discovery rate (FDR) at peptide
level, and peptide ion score >20.
2.7. Native mass spectrometry
The native mass spectrometry measurements used to determine
protein oligomeric states and obtain total mass were conducted
with a modiﬁed Q-ToF (Waters, UK) mass spectrometer adjusted for
enhanced performance in tandem MS  (van den Heuvel et al., 2006).
RcMBL (stored in TBS buffer) were substituted with a 150 mM
ammonium acetate solution through sequential concentration and
dilution steps at 4
◦
C using Amicon Ultra − 15 centrifugal ﬁlter
(Merck Millipore) with a cut-off of 10 kDa. Samples were sprayed
using a standard static nanospray source. Tandem MS  analysis was
conducted by mass-selection of sub-population of ions using the
quadrupole mass analyzer followed by dissociation of precursor
ions induced by their collision with xenon atoms. Data were ana-
lyzed with MassLynx (Waters, UK) and Origin Pro (Origin Lab, USA)
software.
2.8. Glycan array
Glycan binding speciﬁcity of RcMBL was  determined using the
version 5.3 glycan array of the Consortium for Functional Glycomics
(CFG). This array consists of 601 glycans, structures and their cor-
responding CFG numbers are available at the website of the CFG
(http://www.functionalglycomics.org/). Glycan binding was per-
formed essentially as described (Blixt et al., 2004). In brief, RcMBL (2
or 20 g/ml) was  applied to the Glycan array slides in Binding buffer
(150 mM NaCl, 2 mM CaCl2, 2 mM MgCl2, 0.05% Tween-20, 20 mM
Tris-HCl, pH = 7.4), and subsequently incubated with Anti-chicken
MBL  antibody (HYB 182-01-02, Thermo Scientiﬁc) in Binding buffer
(1: 2000 dilution) for 60 min  at RT. Microarray slides were washed
by successive rinses in TPBS buffer (PBS with 0.05% Tween-20),
and overlaid with an Alexaﬂuor 488 labeled goat anti-mouse-IgG
secondary antibodies in phosphate buffered saline (PBS) contain-
ing 0.5% Tween-20. After repeated washes with TPBS, PBS and
deionized water the slides were immediately subjected to imaging.haracterization of recombinant chicken mannose binding lectin.
Fluorescent signal intensity was measured using IMAGENE image
analysis software (BioDiscovery, EI Segundo, CA), mean intensity
minus mean background was  calculated using Microsoft EXCEL
software. For each glycan, the mean signal intensity is calculated
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Fig. 1. Western blotting analysis of RcMBL and NcMBL.
Ten g mannan-puriﬁed RcMBL and serum-derived NcMBL were analyzed usingARTICLEMBIO-51572; No. of Pages 11
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rom 6 replicates spots. The highest and the lowest signals of the 6
eplicates were removed and the remaining 4 replicates were used
o calculate the mean signal, standard deviation.
.9. Salmonella typhimurium agglutination assay
RcMBL-induced bacterial agglutination was assessed by con-
ocal microscopy. Salmonella Typhimurium (DT104) was grown
n Mueller Hinton Broth (MHB, Sigma − Aldrich) at 37 ◦C until
idlog − phase, afterwards the bacteria were spun down and re-
uspended in TBS buffer to a density of 1 × 108 CFU/ml. A hundred
l of bacterial suspension was incubated with various concentra-
ions of RcMBL in the presence of 5 mM CaCl2 for 1 h at 37 ◦C.
ext, the live/dead staining was performed on the bacteria using
he BacLight bacterial viability kit (Invitrogen, USA) with the per-
eant ﬂuorescent probe SYTO 9 and the impermeant ﬂuorescent
robe propidium iodide (PI) according to the manufacturer’s pro-
ocol, in which SYTO 9 and PI stain live (green) and dead (red) cells,
espectively. The mixture was added on top of a 35 mm FluoroDish
WPI, USA) immediately followed by visual analysis with a Leica
PE-II-DMI4000 confocal microscope at the Center for Cell Imag-
ng (CCI), Utrecht University, using 100 × /1.4 − numerical aperture
bjective. Live and dead staining were visualized at 405 nm and
35 nm,  respectively. Representative pictures were obtained after
0 times screen.
.10. Hemagglutination inhibition (HAI) assay
The IAV strains used in this study were a human isolate
/Philippines/82(H3N2) (Phil82) and A/PuertoRico/8/34 (H1N1)
PR-8) that lacks high-mannose oligosaccharides on the globular
omain of its hemagglutinin (HA). The IAV strains were grown
n chorioallantoic ﬂuid of 10-day-old chicken eggs and puriﬁed
n a discontinuous sucrose gradient centrifuge. Virus stocks were
tored at −80 ◦C after dialysis against PBS + + (PBS with 1 mM
aCl2 and 0.5 mM MgCl2). The hemagglutination titer of each virus
as determined by titration of virus sample in PBS + + with thor-
ughly washed human type O, Rh (−) red blood cells (RBC). The
I test was performed by serially diluting RcMBL (25 l) in round
ottom 96 − well plates using PBS + + or PBS + + containing 5 mM
DTA (negative control) as diluents. After adding 25 l of IAV (4
emagglutination units) in each well, the IAV/RcMBL mixture was
ncubated for 30 min  at 37 ◦C. Fifty l RBC (1% suspension in PBS + +)
as added to each well and the plates were incubated for 2 h at RT.
he inhibition was detected by the formation of erythrocyte pellets
s described previously (van Eijk et al., 2011).
. Results
.1. Puriﬁcation and characterization of RcMBL
RcMBL was successfully expressed in Hela R19 cells and puriﬁed
rom the expression supernatant by afﬁnity chromatography using
annan agarose beads. The average protein yield was 1.5 − 2.0 mg
rom 1 l of expression culture. The eluted protein was analyzed by
DS − PAGE and Western blotting. NcMBL, partially puriﬁed from
hicken serum, was used for structural comparison analysis. Both
cMBL and NcMBL showed a band of 33 kDa after Western blotting
nder reducing conditions (Fig. 1). Mannan-puriﬁed RcMBL was
ubjected to size-exclusion chromatography and separated into
wo main peaks (Fig. 2A). Pooled fractions from each peak were
nalyzed by SDS − PAGE and Western blotting. Under non-reducingPlease cite this article in press as: Zhang, W.,  et al., Expression and c
Immunobiology (2016), http://dx.doi.org/10.1016/j.imbio.2016.10.01
onditions the results showed that peak 1 consisted of higher order
ligomeric structures of RcMBL with molecular weights from 120 to
50 kDa and above, while peak 2 contained mainly trimeric struc-
ures ranging from 33 to 70 kDa (Fig. 2B). Under reducing conditionsSDS-PAGE on a 4–15% pre-casting gradient gel under reducing conditions. Visual-
ization of cMBL was done using an anti-chicken MBL  monoclonal antibody (primary)
and a goat anti-mouse IgG antibody (secondary).
the results showed that both peaks migrated as a single band of
33 kDa (Fig. 2B).
3.2. Alignment of cMBL with mammalian MBLs and structural
modelling
The cMBL sequence (Laursen et al., 1998a) reveals that its CRD
contains all sequence features of a C-type lectin and is highly com-
parable to MBL  from other animal species (Fig. 3A). The two most
important structural elements of C-type lectins are the 4 cysteines
that stabilize the characteristic double loop structure (Cys159-
Cys251, Cys228-Cys242) and the 218-EPN-220, 237-WND-239
motifs that are required for ligand binding through coordination
of a calcium ion in the binding pocket of MBL  (Veldhuizen et al.,
2011). All these features are also present in cMBL which is con-
sistent with the observed Ca2+-dependent binding of glycans by
cMBL during puriﬁcation. The predicted 3 dimensional backbone
structure of the neck CRD of cMBL also indicates clearly that cMBL
adopts the classical C-type lectin fold, highly similar to the neck-
CRD of hMBL and to the neck-CRD of human surfactant protein D
(hSP-D) (Fig. 3B–D).
3.3. Mass spectrometry
Native mass spectrometry analysis of RcMBL (peak 2, fraction
containing the trimers) using regular buffer (NH4Ac) resulted in
a mass spectrum with a charge-state-resolution insufﬁcient for
accurate mass determination (Fig. 4A inset), mainly due to the
broadly distributed mass of this heterogeneously glycosylated pro-
tein. To improve the separation of signals representing protein ions
in adjacent charge states we  introduced 20% (mol/mol) triethy-
lammonium acetate (TEAA) into the sample solution which can
partially reduce the charge states (Dyachenko et al., 2013). The
resulting mass spectrum of RcMBL showed signals representing
three distributions of charge states, each of which represented aharacterization of recombinant chicken mannose binding lectin.
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single species (Fig. 4A, blue trace). A preliminary deconvolution
(Wang et al., 2012) revealed that the molecular weights of the sec-
ond and third species are two times and three times that of the
ﬁrst species, respectively. Accurate mass determination of these
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Fig. 2. Puriﬁcation and size exclusion chromatography of RcMBL.
A) Gel ﬁltration analysis of RcMBL was performed on mannan-afﬁnity puriﬁed RcMBL using an ÄKTA puriﬁer10 system with a Hiload 16/60 Superdex 200 PREP GRADE
column. The x−axis and ϒ−axis show the elution time (elution speed: 0.5 ml/min) and optical density at 280 nm,  respectively. Peak 1 and peak 2 are indicated with arrows.
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m)  SDS − PAGE and Western blotting analysis of pooled fractions of peak 1 and pea
micon Ultra-15 centrifugal tube (MWCO10). 10 g of puriﬁed RcMBL proteins fro
R)  or non-reducing conditions (N). CMBL was visualized using an anti-chicken MBL
pecies was performed via tandem MS  measurements, where the
ollision-induced dissociation (CID) employed in the mass analyzer
rovides the protein analytes with maximal desolvation and spe-
iﬁc fragmentation patterns that serve as constraints for accurate
harge assignments (Dyachenko et al., 2015). As exempliﬁed in
ig. 4B, under the TEAA-free condition, mass-selection of ions with
/z centered at 4400 (the largest species) and the subsequent CID
ielded fragment ions carrying 11–13 positive charges and the cor-
esponding residual species in charge states of 6–8. AccordinglyPlease cite this article in press as: Zhang, W.,  et al., Expression and c
Immunobiology (2016), http://dx.doi.org/10.1016/j.imbio.2016.10.019
he molecular weight of the three species, as shaded individually
n Fig. 4A, were determined as 26.1 ± 0.1 kDa, 52.9 ± 0.3 kDa and
9.2 ± 0.4 kDa, respectively (averages from at least three measure-
ents). These molecular weight values and the relative abundanceractions from peak 1 and peak 2 were collected separately and concentrated with
k 1 and peak 2 were analyzed using a 4–15% pre-casting gel under either reducing
oclonal antibody (primary) and a goat anti-mouse IgG antibody (secondary).
depicted in Fig. 4A clearly indicate that RcMBL (from the trimer-
fraction in Fig. 2A) indeed exists as a trimer of three individual
cMBL polypeptides, with minor amounts of monomeric and dimeric
species. Intriguingly, based on the adequately resolved signals
representing the heterogeneous monomers, the average mass dif-
ference between adjacent glycoforms was determined as 0.32 kDa,
implying a difference in mass corresponding to 2 hexoses between
MBL  iso(glyco)forms.haracterization of recombinant chicken mannose binding lectin.
3.4. Glycan array
In order to determine glycan binding speciﬁcity of RcMBL, the
protein was  subjected to glycan array analysis (array version 5.3)
ARTICLE IN PRESSG ModelIMBIO-51572; No. of Pages 11
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Fig. 3. Comparison of the CRD sequence of MBLs and 3D structure prediction of the neck-CRD region of cMBL.
A)  Amino acid sequence alignment of the CRD. Residues in common with the cMBL sequence are indicated with dots and a consensus sequence with residues that are shared
by  all collectins is also provided ‘con’. Asterisks indicate the residues necessary for coordination of Ca2+ ions and ligand binding. Four cysteines stabilizing the double loop
s monomer was predicted using the iTasser programme (http://zhanglab.ccmb.med.umich.
e tif is indicated in red. C) Overlay of the structure of cMBL (green) and hMBL (blue). D)
O  side view (top) and top view (bottom).
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Table 1
Hemagglutination inhibition of IAVs by RcMBL.
RcMBL (g/ml) 40 20 10 5 2.5 1.25
H3N2 (Phil82) Calcium ++++ ++++ +++ ++ + −
EDTA − − − − − −
H1N1 (PR-8) Calcium ++ − − − − −
EDTA − − − − − −
RcMBL (peak 1, multimers) was incubated with IAV (4HAU) for 30 min at 37 ◦C,
followed by 2 h incubation with red blood cells (RBC). Hemagglutination inhibition
was  determined by RcMBL-induced reduction of RBC pellet formation.
‘++++’ indicates full inhibition of RBC pellet formation.tructure of CRD are indicated with a black shadow. B) The architecture of the cMBL 
du/I-TASSER/). The neck region is depicted in blue, CRD in green and the EPN mo
verlay of the structure of cMBL (green) and hSP-D (red). The pictures are shown in
n collaboration with the Consortium for Functional Glycomics (as
escribed in Materials and Methods). RcMBL most strongly bound
o glycans containing terminal mannose (especially high mannose
lycans), fucose or GlcNac residues (Fig. 5). Overall lower binding
as observed for glycans containing terminal galactose residues or
-acetylneuraminic acid. Administering a 10-fold higher amount of
cMBL to the array resulted in a slightly different binding order of
igh binding glycans but very similar overall speciﬁcity. A total list
f all 601 tested glycans and their binding to (two concentrations
f) RcMBL is depicted in Table S1.
.5. Agglutination
Earlier studies have reported that collectins can directly agglu-
inate bacteria, fungi and viruses, an important functional property
hat helps to protect against epithelial infection by these pathogens.
herefore, bacterial agglutination was assessed by incubating mid-
og phase suspensions of Salmonella Typhimurium with RcMBL
peak 1, 20 and 50 g/ml), followed by staining with SYTO9 and PI.
YTO9 is a green ﬂuorescent nuclear counterstain which stains both
ive and dead Gram-negative and Gram-positive bacteria. PI is a red
uorescent nuclear and chromosome counterstain for dead cells
nly. After adding the dye mixture, samples were inspected for dif-Please cite this article in press as: Zhang, W.,  et al., Expression and c
Immunobiology (2016), http://dx.doi.org/10.1016/j.imbio.2016.10.01
erential nuclear staining using a confocal microscope. RcMBL was
ble to agglutinate Salmonella Typhimurium in a Ca2+-dependent
anner, as illustrated by the formation of large aggregates in the
resence of calcium that were absent after incubation in the pres-‘+++, ++, +’ indicates partial inhibition of RBC pellet formation.
‘−‘  indicates no inhibition of RBC pellet formation.
Data shown is from three independent experiments.
ence of EDTA. The control incubation with calcium ions but in
the absence of RcMBL also did not show any agglutination. Direct
bacterial killing is not described for mammalian MBL  and also
RcMBL-induced agglutination did not lead to bacterial death as no
obvious PI staining was observed for the RcMBL-treated samples
(Fig. 6).
3.6. Hemagglutination inhibition of IAV by RcMBLharacterization of recombinant chicken mannose binding lectin.
9
The antiviral activity of RcMBL was measured against two sub-
types of IAV, H3N2 (PHIL82) and H1N1 (PR-8), using a HAI assay. As
shown in Table 1, RcMBL was able to fully inhibit H3N2 IAV induced
agglutination of red blood cells at a concentration of 2.5 g/ml or
ARTICLE IN PRESSG ModelIMBIO-51572; No. of Pages 11
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Fig. 4. Oligomerization analysis of RcMBL and molecular weight determination by native mass spectrometry. (For interpretation of the references to colour in this ﬁgure
legend,  the reader is referred to the web version of this article.)
A  with TEAA (blue). B) A tandem mass spectrum showing the mass-selection of the largest
i lose-up view of the released fragment ions. Intensities of the signals representing residual
s  the corresponding charge states and oligomeric states (in parentheses).
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Fig. 5. Glycan array analysis of RcMBL.
The panel shows the mean plus standard deviation of the binding signals for each
glycan. The highest binding glycans for RcMBL are depicted schematically in the ﬁg-
ure. Glycan numbers indicated on the X-axis corresponds to the structures described)  Native mass spectra of RcMBL (peak 2, trimers) acquired without (inset, red) and
onic  species and its collision-induced dissociation (CID) pattern. The inset shows a c
pecies  were magniﬁed by 10 for better visualization. Signal peaks are labeled with
igher, but was less active against H1N1 IAV as the highest dose
ested (40 g/ml) could only partially inhibit the HA activity of the
R-8 strain. Similar to what was found for RcMBL-induced bacterial
gglutination, the HAI activity of RcMBL was also Ca2+-dependent,
ince all HI activity was inhibited in the presence of EDTA.
. Discussion
Collectin-mediated innate immune responses play an impor-
ant role in the ﬁrst line defense against infections as illustrated
y numerous studies in humans and other mammalian species.
n avian species, however, not much is known about the speciﬁc
ole of these collagenous C-type lectins, including MBL, the most
ell-characterized serum collectin. Thus far, only a few studies
ave provided some insight into the role and function of MBL  in
vian species and how this contributes to chicken health is still not
ell addressed. Since the availability of well-characterized puri-
ed cMBL is very limited, detailed studies are difﬁcult. Therefore,
e aimed to produce a recombinant version of cMBL, and this study
escribes the high-yield expression of RcMBL by the use of HeLa R19
ells. Our study shows that RcMBL can be produced with structural
nd functional properties similar to those of chicken serum-derived
BL.
Previous studies have demonstrated that hMBL can also be suc-Please cite this article in press as: Zhang, W.,  et al., Expression and c
Immunobiology (2016), http://dx.doi.org/10.1016/j.imbio.2016.10.019
essfully produced using different mammalian expression systems.
EK 293 cells and CHO cells are the most commonly used cell
xpression systems, both of which can produce RhMBL that is struc-
urally and functionally similar to native human MBL  (NhMBL).in  supplementary Table S1. Green cycle: Mannose, yellow cycle: Galactose, red tri-
angle: Fucose, blue square: N-acetyl Glucoseamine.
RhMBL assembles into higher oligomers in those cells, and displays
similar carbohydrate binding properties as compared to those of
NhMBL. Furthermore, it can inhibit hemagglutination activity of
IAV and activate the complement system associated with MASPsharacterization of recombinant chicken mannose binding lectin.
(Ahn et al., 2013; Ohtani et al., 1999; Vorup-Jensen et al., 2001).
In our study, HEK 293 and HeLa R19 cells were used for the
production of RcMBL. RcMBL was successfully expressed in both
Please cite this article in press as: Zhang, W.,  et al., Expression and characterization of recombinant chicken mannose binding lectin.
Immunobiology (2016), http://dx.doi.org/10.1016/j.imbio.2016.10.019
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Fig. 6. Ca2+-dependent RcMBL-induced agglutination of Salmonella Typhimurium.
RcMBL (peak 1, multimers) was  incubated with Salmonella Typhimurium (1 × 108 CFU/ml) for 1 h at 37 ◦C, live/dead staining was  performed with ﬂuorescent probe SYTO9
(green) and the impermeant ﬂuorescent probe propidium iodide (red) followed by imaging with confocal microscopy. A) No agglutination was  observed with negative control
(without RcMBL). B) and C) Salmonella Typhimurium agglutination was  observed with 20 and 50 g/ml of RcMBL, respectively, in the presence of 5 mM calcium. D) and E)
Agglutination inhibited by EDTA (ﬁnal concentration of 5 mM)  in the presence of 20 or 50 g/ml of RcMBL, respectively. PI staining indicates the dead cells. Images shown
are  representative for three separate experiments.
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rotein expression systems, SDS-PAGE and Western blotting analy-
is did not reveal major structural differences between both RcMBL
reparations. However, the yield of RcMBL expressed in HEK 293
ells was substantially lower and resulted in strong batch-to-batch
ariations as compared to RcMBL expressed in Hela R19 cells (result
ot shown). Therefore, RcMBL expressed by HeLa R19 cells was
sed in the functional and structural characterization studies.
NcMBL is present in serum as an oligomeric protein, heteroge-
eously assembled into multimeric structures with 2 to 6 trimeric
ubunits (Kawasaki et al., 1983; Laursen et al., 1995; Mizuno et al.,
981). The oligomerization of our RcMBL was determined by gel
ltration and showed that it is assembled as a mixture of trimers
nd higher order oligomers of trimers, similar to NcMBL (Fig. 2).
he majority of oligomers from peak 1 are ranging in mass from
20 to 250 kDa above, while peak 2 mainly contained trimeric
rotein. Reduced SDS-PAGE revealed that RcMBL was detected as
 single band of approximately 33 kDa, which is approximately
 kDa size bigger than the predicated size based on the cMBL
mino acid sequence. Therefore, we also analyzed RcMBL by tan-
em mass spectrometry and determined that the molecular weight
f monomeric RcMBL is approximately 26 kDa, corresponding with
he predicted size. This difference is likely due to differences in
igration behavior on SDS-PAGE between collagen-containing,
ore elongated proteins like MBL, as compared to the globular pro-
eins that were used as molecular weight markers in our SDS-PAGE
xperiments (van Eijk et al., 2002). Western blot analysis of reduced
cMBL and NcMBL showed that both RcMBL and NcMBL migrated
s a 33 kDa polypeptide and both stained positive after immunos-
aining with an anti-cMBL antibody. RcMBL was also identiﬁed by
C–MS/MS analysis of protease-treated RcMBL and data showed
hat more than 70% of the cMBL sequence could be identiﬁed in
he resulting peptides, indicating that the RcMBL had the cor-
ect sequence. Glycosylation of RcMBL was examined by treatment
f PNGase and O-glycosidase, where no indications for glycosyla-
ion could be observed (result not shown). In addition, there is an
bsence of putative glycosylation sites based on the cMBL sequence.
he presence of two hexoses in some of the MBL preparations, as
etermined by mass spectrometry, results in differences too small
o be determined with a band shift on a gel. Probably, these detected
exoses were ligands, bound by MBL.
MBL, like all collectins, belongs to the C-type lectins and this
mplies that it only binds glycans via its CRD in a Ca2+-dependent
anner. The sugar binding activity of the CRD in C-type lectins is
etermined by the presence of 5 key conserved amino acid residues
EPN-E-WND) that are coordinated via the presence of a calcium ion
o facilitate interactions with mannose-type glycans. These inter-
ctions result from the formation of a hydrogen bond network
etween distinct hydroxyl groups of sugars and amino acid residues
f the CRD (Weis et al., 1991, 1992). As previously reported by
aursen (Laursen et al., 1998a), and shown in Fig. 3A, cMBL also con-
ains the EPN-E-WND key residues that are conserved in MBL  from
ll animal species that have been characterized to date (Laursen
t al., 1998a). The observed glycan speciﬁcity of RcMBL, as deter-
ined in this study using a glycan array was indeed typical for a
annose type of C-type lectins. Mainly terminal mannose, N-acetyl
lucosamine and fucose residues were required for strong bind-
ng to RcMBL. Laursen et al. had previously determined binding
peciﬁcity of monosaccharides to NcMBL using a competition assay
Laursen et al., 1995). Of the monosaccharides tested ManNac, Glc-
ac mannose and fucose were capable of inhibiting cMBL binding to
annan. Despite the relative low number of glycans tested, these
esults correlate well to our results, considering that the glycanPlease cite this article in press as: Zhang, W.,  et al., Expression and c
Immunobiology (2016), http://dx.doi.org/10.1016/j.imbio.2016.10.019
rray used does not contain terminal ManNac residues. Similarly,
lycan binding of MBL  of other species also have a mannose type ﬁn-
erprint (Childs et al., 1990; Haurum et al., 1993) indicating that no
ajor speciﬁcity for certain glycan binding seem to exist for avian PRESS
gy xxx (2016) xxx–xxx 9
MBL  compared to mammalian MBL. However, more subtle differ-
ences could have major functional consequences for recognition of
pathogens or host (immune) cells.
The 3-dimensional structure of the neck-CRD domain of cMBL
was also predicted by the iTasser programme (Yang et al., 2015).
Overlay modelling showed that the neck-CRD fold of cMBL strongly
overlaps to that of both hMBL and hSP-D (Fig. 3). Interestingly, the
angle between neck and CRD of cMBL seems to resemble more that
of hSP-D than hMBL. Any functional consequences for this are only
speculative but are worthwhile to investigate. Overall the structure
further underlines that the CRD conformation of cMBL fulﬁlls the
criteria of being a C-type lectin (the C-type lectin structure has also
been reviewed in (Hakansson and Reid, 2000; Veldhuizen et al.,
2011)).
The biological activity of RcMBL was  investigated by testing its
antibacterial and antiviral properties. First, RcMBL was tested for its
potency to agglutinate bacteria, using Salmonella Typhimurium, a
bacterial species known for its wide range host infection, including
human and chicken, that causes localized self-limiting gastroen-
teritis (reviewed in (Calenge et al., 2010; Ohl and Miller, 2001)).
The binding of MBL  to Salmonella is strain-dependent and mainly
depends on the degree of glycosylation of the O-antigen, while the
3-dimensional structure of the lipopolysaccharide (LPS) also plays
an important role in determining MBL  attachment to this microor-
ganism (Devyatyarova-Johnson et al., 2000). In our study, RcMBL
was able to agglutinate bacteria into large aggregates in the pres-
ence of calcium ions, but this aggregation was no longer observed
in the presence of EDTA. This result is in contrast with a previous
study that showed that NcMBL was  not capable to bind Salmonella
Typhimurium (Ulrich-Lynge et al., 2015). This difference in out-
come might be due to structural differences between individual
strains that can inﬂuence the interactions with MBL, for instance,
the complexity of glycan on the microbial surface, the structure and
composition of bacterial endotoxins, and the expression of capsular
polysaccharide of bacteria (Neth et al., 2000).
It has been described in several studies that collectins also play
an important role in neutralization of viral infections, including
MBL  (Hartshorn et al., 1997). We  also tested RcMBL for its HAI
activity against different subtypes of IAV. The in vitro interactions
between MBL  and IAV has been well-documented, including inhi-
bition of viral hemagglutination, blocking of viral neuraminidase
activity, opsonization of IAV resulting in increased uptake and
activation of neutrophils, neutralization of IAV infectivity, and
activation of the complement system to promote lysis of IAV or
IAV-infected cells (reviewed in (Ng et al., 2012)). The binding of
MBL to IAVs occurs via interactions between the CRD of MBL, and
the glycosylated viral spike proteins HA and NA, and depends on
the degree and location of N-glycosylations present on the globu-
lar head region of HA (Job et al., 2010; Reading et al., 1997). This is
illustrated by studies with the PR-8 (H1N1) strain which is highly
resistant to binding and neutralization by MBL  as well as SP-D,
because PR-8 does not carry any glycosylation sites on the head
region of its HA (Reading et al., 1997). The presence of mannose-
type oligosaccharides on the HA domain of IAV is considered the
discriminating factor that determines interactions between MBL
and IAVs. This is further illustrated by the ability of MBL  to neutral-
ize Phil82 (H3N2) much more efﬁciently as compared to the mutant
strain Phil82BS which lacks the high-mannose glycan moiety over-
lying the receptor binding site of the parent Phil82 strain (Chang
et al., 2010). In our study, we tested the HAI activity of RcMBL
against both PR-8 (H1N1) and Phil82 (H3N2) and, as expected,
RcMBL exhibits strong HAI activity against H3N2 requiring a rel-haracterization of recombinant chicken mannose binding lectin.
atively low concentration of RcMBL (2.5 g/ml) for neutralization
of this strain. In contrast, the HAI activity of RcMBL on H1N1 is
very limited, only the highest concentration tested (40 g/ml) can
partially inhibit the viral-induced agglutination of red blood cells.
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he HAI activity of RcMBL against IAV is completely lost in the
resence of EDTA, indicating that the interaction between RcMBL
nd IAV is mediated via the Ca2+-dependent CRD of RcMBL, simi-
ar to what was found for hMBL and SP-D. Taken together, these
ndings underline that the CRD of RcMBL is fully functional in
he presence of calcium ions, and that this domain is responsi-
le for the interactions between RcMBL and bacterial and viral
athogens. Importantly, since our RcMBL preparations do not con-
ain the protease zymogen MASP2 (chickens lack MASP 1 and is
herefore totally MASP2 driven)(Lynch et al., 2005), we are not able
o examine RcMBL-induced complement activation in this study.
his requires MASPs or MBL-free serum from chickens.
In conclusion, we successfully expressed a recombinant ana-
ogue of MBL  from chickens in Hela R19 cell with structural and
unctional properties similar to that of serum-derived NcMBL. Like
cMBL, RcMBL assembles into higher order oligomers and exhibits
a2+-dependent sugar binding that is typical for C-type lectins.
cMBL is a fully functional protein as demonstrated by its potential
o agglutinate Salmonella Typhimurium and to inhibit HA by IAVs.
his RcMBL enables to study the role of MBL  in non-mammalian
pecies and provides a useful tool for the investigation of its activi-
ies against avian pathogens as well as its role in the innate immune
ystem.
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